— President of NADDI —
The President works closely with the Executive Director to handle the day-to- day operations of the NADDI organization and has the authority to execute the duties as approved by the Executive Board.
Jim Schwartz has helped to shape the future of NADDI organization and has the diverse skills to lead us forward. He is an inspiration to the organization.
Phone: (443) 235-3184
MORE ABOUT JAMES "JB"
Jim “JB” Schwartz has been a member of the National Association of Drug Diversion Investigators since 2005. Prior to his appointment to NADDI National President in November of 2019, Jim served as the NADDI National Secretary and as the National Vice-President. Jim also served as the President of the NADDI Maryland State Chapter for five years.
Jim is a 22-year veteran with the Ocean City Police Department located in Ocean City, MD and is currently assigned to the Patrol Division as a Sergeant. Jim has spent a majority of his career in the Criminal Investigation Division investigating a multitude of drug crimes – especially pharmaceutical drug diversion investigations.
In 2015, Jim testified in front of the Maryland Senate and House of Delegates on behalf of NADDI, in favor of FDA approved Abuse Deterrent Formulations to be available to patients to help combat opiate abuse. Jim has also traveled around the country lecturing about the dangers of pharmaceutical drug diversion and what can be done to help combat the problem.
Jim has received numerous awards for his service, especially in the field of narcotics enforcement including the Enrique S. Camarena Award; the Maryland Chiefs of Police Exceptional Police Performance Award; the Ocean City Police Department’s Neighborhood Watch Police Officer of the Year award; two bronze stars, a meritorious service award, excellent police performance award, and three unit citations for exceptional police work in narcotics enforcement.
Jim is honored to be a member of NADDI and a part of such an elite organization that works to develop and implement solutions to the problem of prescription drug abuse and diversion.